【3分で解説 #世界のファーマ】第30回 米国、ジェネリック関税に国内外から懸念／BMSとAZ合併の噂 (Japanese-language podcast) Aug. 28, 2026
Citeline PodcastsShow Notes
世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で発信する2つのオンラインメディアから、今注目の話題を日本語で短くまとめてお届けします。今回取り上げた記事はこちら.
As US Threatens A Tariff Bomb On Generic Drugs, Will Exemptions Be Negotiated? https://insights.citeline.com/pink-sheet/policy-regulation/as-us-threatens-a-tariff-bomb-on-generic-drugs-will-exemptions-be-negotiated-6NUJIGIPNFCT5HRSSIEIXJSJZY/
Trump Tariff Action On Generics Highlights Temporary Nature Of Exemptions https://insights.citeline.com/scrip/business/strategy/trump-tariff-action-on-generics-highlights-temporary-nature-of-exemptions-GJOW5MWMOJBKLEWSDMM222DTYI/
Trump’s Generic Tariff Clock Demands Compression Of US FDA Review Timelines https://insights.citeline.com/pink-sheet/biosimilars-and-generics/trumps-generic-tariff-clock-demands-compression-of-us-fda-review-timelines-5C4DXMVVCRGRRGXG2QRUH62GTQ/
BMS Likely Main APAC Beneficiary Of Any AstraZeneca Mergerhttps://insights.citeline.com/scrip/business/deals/bms-likely-main-apac-beneficiary-of-any-astrazeneca-merger-NVNVSZTPHFBAXHZR6H6IPI35JU/
※全文の閲覧には購読（有料）が必要です。世界の製薬ビジネスメディアScrip（スクリップ）とは？https://www.citeline.com/ja-jp/products-services/commercialization/scrip
More from Citeline Podcasts
Ahead of the awards presentation on Dec 2, the Scrip Awards podcast speaks to Mathai Mammen, CEO of Parabilis, one of the shortlisted companies for Biotech of The Year.
Disease-modifying Alzheimer’s treatments have arrived, but diagnosing the right patients at scale is still a major bottleneck. In this episode of Strategic Intent, Marion Webb (MedTech Insight) speaks with Dr. Soeren Mattke, research professor of economics at USC, director of the Brain Health Observatory, and member of the scientific advisory board of ALZpath, about how FDA-cleared blood tests are changing the picture.
In the latest episode of Off-Patent, On Record, Generics Bulletin’s senior reporter Urtė Fultinavičiūtė talks to the International Generic and Biosimilar medicines Association’s secretary general Ana Gaunt to mark the start of Global Biosimilars Week, a worldwide awareness and education campaign spotlighting the importance of biosimilars.
Pink Sheet Executive Editor Derrick Gingery, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobbs discuss the reasons Iilun Murphy, director of the US Food and Drug Administration’s Office of Generic Drugs, decided to step down (:53) and whether the move should concern senior agency officials (2:51). They also consider the FDA’s plan to create a fit-for-purpose rare disease approval framework (12:19), how it will connect with the agency’s litany of programs for the products (14:52) and the potential difficulties of systematizing regulatory flexibility (18:22).
本期播客内容来自《Scrip》杂志，精选内容涵盖截至2026年10月9日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。本周内容包括：中国带来的竞争威胁；第三季度并购活动降温；新型肺炎球菌疫苗竞争者；西班牙生物技术公司的战略；以及盐野义制药20亿美元的收购案。Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-ZCXOSRSNEBCARAW4DUWENVCPSQ/向听众们简要更新一下：Scrip现在已在Spotify和Apple Podcasts上开设了专属播客频道。Feedback: [email protected]